Dog Dewormers Market

Report ID: GMI11674
Download Free PDF
Summary
Table of Content

Dog Dewormers Market Size

The global dog dewormers market size was valued at around USD 1.4 billion in 2023 and is estimated to grow at a 9.5% CAGR from 2024 to 2032. The global concern for zoonotic diseases and an increase in pets are the factors influencing the growth of the market.

Dog Dewormers Market

To get key market trends

COVID-19 fostered pet adoption owing to pet owners' lifestyle changes and urbanization, especially in developed nations. For instance, as the American Pet Products Association cited, 66% of the US Population owned pets in 2023. Moreover, in 2022, pet spending particularly with regards to veterinary services increased to USD 35.9 billion. All of this cumulatively drives up demand for dog dewormers in the country. Pet owners value prevention when it comes to their pets' health.

Dog Dewormers Market Trends

There are rising technologies being adopted for dog dewormers, it is gradually carving out its place in the market. Such advancing technologies focus on making the medicines safer and more effective, which, in turn, makes it easier for more pet owners to adopt regular deworming practices.

  • ProHeart 12 is an injectable anti-parasitic medication that boasts improved compliance and convenience for pet owners, as one dose can protect dogs against heartworms and intestinal parasites for up to twelve months. Both improvements mean that the hassle of frequent dosing is eliminated alongside long-term protection, making it easier for pet owners.
  • Additionally, Interdector Plus and NexGard are two well-known names in the field specifically designed to keep safe animals from varied internal and external parasites, offering an all-in-one solution. These solutions are quite simple for pet parents as they require less monitoring and fewer prescriptions to ensure the pet's parasite problems are under control.
  • In addition, new injectable and topical dewormers are designed with better delivery systems and have greater absorption with fewer adverse effects. Such technologies guarantee perfect dosages and ease of administration for pets that have difficulties with oral medication. These advancements also make the process of dog deworming more effective, easier, and safer, which drives the growth of the market.

Dog Dewormers Market Analysis

Dog Dewormers Market, By Product Type, 2021 - 2032 (USD Billion)
Learn more about the key segments shaping this market

Based on product type, the market is classified into tablets and chewable treats, topical solutions, and injections. The tablets and chewable treats segment generated the highest revenue of USD 768.6 million in 2023.

  • Tablets and chewable treats lead the market for dog dewormers because they are easy to use and within pet owner compliance. These types of forms are much less problematic when administered to a dog because chewables tend to be flavored and will be eaten, not spat out.
  • Also, chewable treats as well as tablets are very easily available over the counter; thus, accessible to a wider network of pet owners. Their affordability in comparison to other alternatives, such as injections or topical solutions, is also responsible to their market dominance. These factors together increase their market share.
Dog Dewormers Market, by Distribution Channel (2023)
Learn more about the key segments shaping this market

Based on the distribution channel, the dog dewormers market is classified into veterinary clinics, retail pharmacies, online platforms, and pet stores. The veterinary clinics segment generated the highest revenue of USD 560.2 million in 2023.

  • Pet owners seeking deworming solutions visit veterinarians for professional diagnosis and personalized treatment recommendations, fully aware that the products provided would be appropriate for the pet's health challenge and would, therefore, be safe and effective for use.
  • Furthermore, even moderately effective formulations such as granules that have higher potency are only available in veterinary clinics.
  • Hence, prescription-strength dewormers, which cannot be purchased from retail pharmacies or online, are the main reasons why veterinary clinics are frequently where pet owners go to purchase dewormers.
 North America Dog Dewormers Market, 2021 - 2032 (USD Million)
Looking for region specific data?

North America's dog dewormers market accounted for USD 513.3 million in revenue in 2023 and is anticipated to grow at a CAGR of 9.1% between the 2024–2032 period.

  • Pet population in the North American region is highest. Moreover, there is growth in ownerships of pets, which is enhancing demand for dog dewormers as owners look to keep their pets parasite-free.
  • Moreover, North America has a developed market for preventive animal healthcare products and services, which helps in educating pet owners about the possibilities and risks of parasitic infections so that they can take appropriate action through regular deworming.

The U.S. held a dominant position in the dog dewormers market, with revenue of USD 473.5 million in 2023.

  • In the U.S., there is heavy spending on veterinary services due to the increased attention that pet owners devote to the health of their pets, including spending on preventive treatments such as dewormers aimed at keeping the pets in good health.
  • Moreover, the market is characterized by innovation in pet care, including dewormers. The introduction of new and more effective dosage forms such as extended release and combination products stimulates growth by making these items more convenient and easier to use.

The UK dog dewormers market is anticipated to witness substantial growth from 2024 to 2032.

  • Regulatory policies in the UK tend to focus on pet healthcare, with routine deworming and preventive parasite control as priority areas. Such regulatory support enables pet owners to adhere to schedules for scheduled deworming.
  • Further, the comprehensive veterinary care standards, which include preventive measures in the UK, also tend toward effective pet deworming solutions. To meet these high standards, pet owners are more likely to comply with recommended deworming regimens.

Japan holds a dominant position in the Asia Pacific dog dewormers market.

  • In Japan, novel programs related to pet care and new clinics that provide broader health services, including advanced pet deworming, are becoming popular. These programs quicken the growth of the market by specializing in other dog-illness specific services.
  • Moreover, people in Japan tend to culturally ensure that their pets live long and healthy lives and take measures to do so. This cultural aspect leads to investment in health maintenance activities that provide preventive treatment such as deworming to prolong and improve the pets' lives.

Dog Dewormers Market Share

The market for dog dewormers is fragmented, populated by a myriad of multi-national corporations and mid-sized and small firms competing for market share. The expansion and growth of companies in this segment revolves around developing and introducing new efficient and economical deworming remedies.

This innovative approach fuels competition and developments within the market as firms attempt to meet changing clinical requirements and pet health needs. Companies strive to increase their market capture by novel formulations and delivery systems in order to meet the growing sophistication of dog deworming needs.

Dog Dewormers Market Companies

Some of the eminent market participants operating in the dog dewormers industry include:

  • Bayer AG
  • Beaphar
  • Bimeda, Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Durvet Animal Health Products
  • Elanco Animal Health Incorporated 
  • Jurox Pty Limited
  • Merck & Co., Inc.
  • Ourofino Animal Health
  • PetIQ, LLC.
  • Sava Healthcare Limited
  • Vetoquinol
  • Virbac SA
  • Zoetis Inc.
  • Boehringer Ingelheim develops well-tolerated dewormers for dogs of all breeds which makes elimination of pets’ parasites simple and effective.
  • Elanco is known for new and simple to use dewormers that meet the growing needs of pet owners and practitioners.
  • Zoetis offers sophisticated parasite control solutions that are safe and effective for dogs of all breeds and sizes.

Dog Dewormers Industry News: 

  • In April 2024, Boehringer Ingelheim announced the launch of NexGard SPECTRA in India, following its approval by the Central Drugs Standard Control Organization (CDSCO). This represented an expansion of the NexGard product line and is expected to generate revenue for the company.

Dog dewormers market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 to 2032 for the following segments:

Market, By Product Type

  • Tablets and chewable treats
  • Topical solutions
  • Injections                          

By Distribution Channel

  • Veterinary clinics
  • Retail pharmacies
  • Online platforms
  • Pet stores

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Netherlands
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East and Africa

 

Author: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :

Some of the prominent market participants include Bayer AG, Beaphar, Bimeda, Inc., Boehringer Ingelheim International GmbH, Ceva Sant

In 2023, North America's market recorded USD 513.3 million in revenue and is anticipated to grow at a CAGR of 9.1% between 2024 and 2032. The high pet ownership rates in the U.S. and Canada drive this demand, as owners seek to keep their pets free from parasites.

The industry was valued at approximately USD 1.4 billion in 2023 and is projected to grow at a 9.5% CAGR from 2024 to 2032, driven by increased pet ownership and a rising focus on zoonotic diseases.

Tablets and chewable treats generated the highest revenue of USD 768.6 million in 2023. Their popularity stems from their convenience, ease of administration, and high compliance rates among pet owners.

Dog Dewormers Market Scope

Related Reports

Buy Now

Premium Report Details

Download Free Sample